Chemoprophylaxis of malaria.
D000293:Adolescent; D000328:Adult; D000349:Africa; D000743:Anemia, Hemolytic / Q000139:chemically induced; D001208:Asia; D001315:Australia; D002648:Child; D002675:Child, Preschool; D002738:Chloroquine / Q000009:adverse effects / Q000627:therapeutic use; D003622:Dapsone / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use; D004338:Drug Combinations; D004351:Drug Resistance; D005260:Female; D006801:Humans; D007223:Infant; D007700:Kinetics; D008288:Malaria / Q000517:prevention & control*; D010139:Pacific Islands; D011247:Pregnancy; D011319:Primaquine / Q000009:adverse effects / Q000627:therapeutic use; D011739:Pyrimethamine / Q000009:adverse effects / Q000627:therapeutic use; D013413:Sulfadoxine / Q000009:adverse effects / Q000627:therapeutic use; D014195:Travel
D004338:Drug Combinations; D013413:Sulfadoxine; D002738:Chloroquine; D003622:Dapsone; D011319:Primaquine; D011739:Pyrimethamine